Fig. 1 · Structure
Documents & Downloads
BBMP
Permeability Transition Pore Inhibitor
BBMP is an inhibitor of the permeability transition pore (PTP), actively preventing Ca2+-induced permeability transition and subsequent mitochondrial depolarization. This compound exhibits potential for research applications in neurodegenerative disorders, making it valuable for studies focused on mitochondrial dysfunction and cellular injury pathways.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 97120-13-3 |
| Applications | Permeability Transition Pore Inhibitor |
| Formula | C12H11BrN2O3S |
| Molecular Weight | 343.20 |
| Synonyms | 5-(Benzylsulfonyl)-4-bromo-2-methyl-3(2H)-pyridazinone |
| SMILES | O=C1C(Br)=C(S(=O)(CC2=CC=CC=C2)=O)C=NN1C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.